PTK2 and breast carcinoma: VS-4718 promotes caspase-3 activation by blocking FAK and p130Cas tyrosine phosphorylation, which leads to apoptosis in breast cancer cells (4T1) and reduces tumor growth and metastasis in breast cancer [74].